A major breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial tumor inhibitor protein is frequently disabled in various types of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research